通过ROS放大纳米催化剂诱导的多器官应激性亡,用于增强癌症免疫治疗
Zhe Yu1, Haozhe Ren2,3,3, Hua Li4
1Department of Pharmaceutical Analysis, School of Pharmacy, The Fourth Military Medical University, Xi'an, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 5, 2026
概括
这项研究介绍了一种基于铁的新型纳米药物,通过触发非传统的细胞死亡途径 - - 亡来增强化学动力疗法 (CDT). 这种方法克服了过氧化 (H2O2) 和亡耐药性的局限性,增强了抗瘤免疫力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 化学动力学疗法 (CDT) 面临的挑战是由于细胞内缺少过氧化 (H2O2) 和对亡的抗性.
- 开发新的策略来提高CDT的疗效和克服治疗耐药性对于癌症治疗至关重要.
研究的目的:
- 设计一个自供H2O2的纳米平台,并阻断自流量以增强CDT.
- 为了研究诱导亡作为癌症治疗的新型细胞死亡途径.
- 评估纳米平台与免疫治疗的协同效应.
主要方法:
- 一个多孔的Fe3O4纳米平台的制造,装载了碳酸3-烯化 (CCCP) 和乳酸氧化酶 (LOD).
- 在体外和体外评估纳米平台产生H2O2,诱导氧化应激,并触发帕帕托斯细胞死亡的能力.
- 对纳米平台的免疫细胞死亡和与αPD-L1进行增强抗瘤免疫力的联合治疗的评估.
主要成果:
- 纳米平台有效地释放了Fe离子,并在瘤微环境中产生了H2O2,克服了H2O2缺乏.
- 通过CCCP介导的线粒体解放大了反应性氧物种 (ROS) 泄漏,导致多器官应激和亡.
- 组合疗法证明了抗瘤免疫力的强烈激活,并显著抑制了初级和远程瘤.
结论:
- 开发的以铁为基础的纳米药物有效触发了帕帕托斯,为提高CDT疗效提供了一种新的策略.
- 多器官应激协同作用和帕帕托斯诱导是克服癌症治疗耐药性的有希望的方法.
- 这种纳米平台具有组合治疗的潜力,可以显著改善癌症治疗中的免疫治疗结果.
相关概念视频
Electron Transport Chain: Complex I and II
19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
Autophagic Cell Death
4.8K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
Autophagy
6.0K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
The Extrinsic Apoptotic Pathway
9.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K


